Inventory Disclosure
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Prescription drugs and medical supplies | 5,645) | 4,777) | 3,722) | 3,165) | 2,661) | ||||||
Inventories | 5,645) | 4,777) | 3,722) | 3,165) | 2,661) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Item | Description | The company |
---|---|---|
Inventories | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. | Cigna Group inventories increased from 2021 to 2022 and from 2022 to 2023. |